A New Drug for Cataract Surgery Leaves at Least 68 People Nearly Blind

A botched knockoff of the drug Tri-Moxi (which is often injected into a patient’s eye during cataract surgery) has caused at least 68 people in the Dallas area to suffer partial blindness or worse within days or weeks of being injected in the eye during routine cataract surgery. The original inventors of Tri-Moxi, Imprimis, have maintained that the original formula is safe. The alleged purpose of Tri-Moxi is to prevent swelling, infection, and dryness of the operated eye.

However, the Professional Compounding Centers of America, who allegedly invented the knockoff Tri-Moxi drug recipe, and Guardian Pharmacy Services, the pharmacy that allegedly mixed it, have been accused of being responsible for causing those injected with the drug to see glares, spots, halos, flashing lights, or, in some cases, complete darkness. Many people injected with the drug are constantly disoriented, plagued with headaches and nausea, and unable to drive or work.

Both organizations and the clinics that performed the surgeries have rejected blame and are pointing their fingers at one another. The company alleged of coming up with the knockoff Tri-Moxi drug recipe, the Professional Compounding Centers of America, denies the blame for vision loss and alleges that the harm was caused in part by the pharmacy that mixed it, Guardian Pharmacy Services. Guardian, on the other hand, claims that there is no link between its products and the patients’ vision problems. Further, the clinics that performed the surgeries with the knockoff version of the Tri-Moxi drug, the Key-Whitman clinic and the Park Central Surgical Center in Dallas, claim the drug was certainly to blame.

If you or someone you know has been injured by the negligence or wrongdoing of another person or company, contact an experienced attorney at Abraham, Watkins, Nichols, Agosto, Aziz & Stogner by calling (713) 222-7211 or toll free at 713-222-7211.